Log in to save to my catalogue

HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond

HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1767068842

HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond

About this item

Full title

HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Nephrology, 2016-03, Vol.12 (3), p.157-168

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Key Points
Erythropoietin production is controlled by hypoxia inducible factor (HIF); the prolyl hydroxylase domain-containing (PHD) enzymes regulate HIF and act as molecular oxygen sensors
Small-molecule inhibitors of the PHD enzymes increase erythropoietin production and are in clinical development for the treatment of renal anaemia
Adva...

Alternative Titles

Full title

HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1767068842

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1767068842

Other Identifiers

ISSN

1759-5061

E-ISSN

1759-507X

DOI

10.1038/nrneph.2015.193

How to access this item